In November 2020, we introduced the J&J Workforce Vaccine Taskforce with the primary goal to enable our workforce and their families to gain efficient access to COVID-19 vaccines, if and when they become available, through an appropriate, and informed approach.
While many efforts of the taskforce are still being planned and confirmed, we wanted to share a few updates and plans moving forward.
Click here to learn more.
Posted on: 1/11/2021
Eligible individuals 65+ with an iPhone who are covered by Medicare Advantage plans can now enroll in the Heartline™ Study.
Heartline is a virtual research study designed to explore how everyday technology like the iPhone and Apple Watch can enable earlier detection of atrial fibrillation, a leading cause of stroke. Previously, the study was only open to eligible individuals with Original (Traditional) Medicare.
Participating in the Heartline Study is one way you can partake in heart health education and activities that may help improve your sleep, fitness and wellness - all from the comfort of your home.
Click here to learn more.
Posted on: 10/12/2020
We are continually evaluating the Johnson & Johnson Savings Plan investment options to ensure we are providing a diverse set of choices that can help you meet your financial and retirement goals by not placing too much of your retirement savings in any one company or industry. Starting September 1, 2020, we are implementing a new 20% investment limit on the amount that participants may allocate in the Johnson & Johnson Common Stock Fund within the Savings Plan. Click here to learn more.
Posted on: 7/6/2020
On May 19th, 2020, Johnson & Johnson Consumer Health announced our plans to discontinue the commercialization of talc-based Johnson’s Baby Powder in the U.S. and Canada by the end of 2020 as part of a broader portfolio simplification program. Cornstarch-based Johnson’s Baby Powder will remain available in North America. Both types of Johnson’s Baby Powder – talc-based and cornstarch-based – will continue to be sold in other markets around the world where there is significantly higher consumer demand for the product. Read more for the announcement.
Posted on: 5/19/2020
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use. Click here for more information.
Together we can make a difference. In response to the COVID-19 pandemic, Johnson & Johnson is donating $1 million to two organizations—COVID-19 Solidarity Response Fund and the CDC Foundation’s ALL OF US Campaign—making employee and retiree donations go further by matching individual contributions to each organization dollar to dollar up to $1 million. Donate now.
As a way to offer the best care possible in light of the COVID-19 pandemic, UnitedHealthcare is offering their HouseCalls Program in a virtual setting. Members who have an email and webcam capability may participate in a virtual nurse HouseCall visit. If you were scheduled for a HouseCall visit at home, a Scheduling Coordinator will reach out to you by phone to offer a virtual visit. If you have questions, please contact UnitedHealthcare at the number on the back of your member ID card.
With the rapidly evolving circumstances related to the coronavirus (COVID-19) pandemic, there is a lot of health information in the public domain that can be confusing, conflicting or inaccurate. It can be difficult to understand who or what to believe. Watch the question and answer session held with Johnson & Johnson medical experts in your local language by selecting your language in the closed captioning menu
Click here for guidance from UHC on what you need to know about The Novel Coronavirus.
As the coronavirus (COVID-19) pandemic continues to expand
in our region, Johnson & Johnson is taking additional steps to protect our
employees around the world and to ensure our facilities remain safe so we can
continue to make critical medicines, devices and products for our patients and
consumers. With this is mind, our on-site Fitness Facilities will be
closed for two weeks effective close of business Monday, March 16th.
Your Wellness Professionals will remain available via email to assist
with your well-being needs and would welcome a friendly message to keep in
be aware that Global Health Services (GHS) and the Global Security Operations
Center monitor public health data 24-hours-a-day to ensure we can respond
quickly to any changing health risk. The Crisis Management Team is
continuing to monitor the situation and will provide updates as the situation
continues to evolve.
Over the past few weeks a new
virus emerged across China, known as the Coronavirus. Johnson & Johnson is
swiftly responding to address this emerging health crisis. Watch the video below
to hear from Dr. Paul Stoffels, Vice-Chair of the Executive Committee and Chief
Scientific Officer, on how the world leaders at the World Economic Forum in
Davos, Switzerland are mobilizing as an industry as quickly as possible to get
to diagnostics, new medicines, and interventions to prevent more people from
getting infected. Click here for more information.
As the global situation related to the coronavirus (COVID-19) continues to evolve, Johnson & Johnson is taking precautions to support the safety and well-being of our employees and the communities in which we live and work. Click here to read more.
In celebration of the Year of the Nurse and Midwife, Johnson & Johnson and the American Nurses Association are pleased to launch SEE YOU NOW, an inspiring external podcast series that spotlights nurses who are driving innovative solutions for today's most challenging healthcare problems.Subscribe today wherever you find your podcasts and join in the online conversation at #SeeYouNow.
Your New Retirement Investment OptionsLast September 30, 2019, nine new custom target date fund investment options (also known as the Target Retirement Funds) were introduced to the Johnson & Johnson Savings Plan. With the launch of the custom target date funds, the Balanced Fund was eliminated. Any amounts invested in the Balanced Fund on September 27, 2019, were automatically transferred to the Target Retirement Fund that most closely aligns with the year the participant will reach age 62. As always, how you invest your money is up to you.Click here for a letter that covers important details. We have also created a brochure to help you make informed decisions about your new investment options. Additional information is available on the For Your Benefit (FYB) website.
Turn over a new leaf with your voluntary benefits from Added Benefits®. As a retiree of Johnson & Johnson, you could enjoy special savings not available to the general public on reliable coverage for your automobiles, home1, personal property, and pets. Plus, you can access special discounts at your favorite retailers.
Call 1-888-332-4134 or visit www.AddedBenefitsJJ.com to participate.
Dear Johnson & Johnson Retiree,
The J&J North America Government Affairs department is pleased to announce a new grassroots advocacy website designed for employees and retirees. The Johnson & Johnson Political Information Network JJPIN site is your one-stop resource for the company’s current federal and state legislative priorities, your legislators and nonpartisan voting information. Also, as appropriate, you may be asked to voluntarily weigh in with your elected representative about an important piece of legislation with significant impact to our business. Please take a moment to visit the site at: www.jjpin.com. Registration is as easy as signing onto the online company store. Your voice makes a difference. Thank you.
The safety of those who use our products is our top priority and every decision we make is grounded in Our Credo responsibilities. Click Here for a message from Kathy Wengel, Executive Vice President & Chief Global Supply Chain Officer, providing an update on our U.S. single lot recall of Johnson's Baby Powder. Additional information about our talc can always be found at our website, https://www.factsabouttalc.com/
As you may have heard, a decision has been reached in the Oklahoma opioid trial involving Johnson & Johnson. Click here for a message from Michael Ullmann, Executive Vice President, General Counsel, Johnson & Johnson, which was distributed to U.S. employees. For more information, please visit this website that shares facts and context related to our prescription opioid medications and our legal response.
This website is solely for retirees of the Johnson & Johnson Family of Companies, and will help you reconnect with colleagues, stay up to date on the latest Johnson & Johnson news, and take advantage of everything available to you as a retiree.
For over 125 years, the employees of the Johnson & Johnson Family of Companies have worked to advance the health and well-being of people throughout the world. Thank you for your contributions in pursuit of this goal.
To access your benefits information, click here to visit the For Your Benefit (FYB) website (Use the Chrome, Edge, or Firefox browsers for an optimal experience).
Benefit Service Center: 1-800-565-0122
Click Here for COVID-19 updates from Johnson & Johnson benefit service administrators.
NYSE : JNJ
Your Equity Awards
ARAG Legal Insurance Plan